181 related articles for article (PubMed ID: 16369044)
1. Natural human antibody responses to Plasmodium vivax apical membrane antigen 1 under low transmission and unstable malaria conditions in Sri Lanka.
Wickramarachchi T; Premaratne PH; Perera KL; Bandara S; Kocken CH; Thomas AW; Handunnetti SM; Udagama-Randeniya PV
Infect Immun; 2006 Jan; 74(1):798-801. PubMed ID: 16369044
[TBL] [Abstract][Full Text] [Related]
2. Comparison of naturally acquired antibody responses against the C-terminal processing products of Plasmodium vivax Merozoite Surface Protein-1 under low transmission and unstable malaria conditions in Sri Lanka.
Wickramarachchi T; Illeperuma RJ; Perera L; Bandara S; Holm I; Longacre S; Handunnetti SM; Udagama-Randeniya PV
Int J Parasitol; 2007 Feb; 37(2):199-208. PubMed ID: 17055511
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to Plasmodium vivax apical membrane antigen 1: persistence and correlation with malaria transmission intensity.
Morais CG; Soares IS; Carvalho LH; Fontes CJ; Krettli AU; Braga EM
Am J Trop Med Hyg; 2006 Oct; 75(4):582-7. PubMed ID: 17038677
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the genetic diversity of domain II of Plasmodium vivax Apical Membrane Antigen 1 (PvAMA-1) and the ensuing strain-specific immune responses in patients from Sri Lanka.
Dias S; Somarathna M; Manamperi A; Escalante AA; Gunasekera AM; Udagama PV
Vaccine; 2011 Oct; 29(43):7491-504. PubMed ID: 21784116
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Naturally Acquired Antibody Responses to Two Variant Forms of Plasmodium vivax Apical Membrane Antigen-1 in Individuals Living in Areas of Low and Unstable Malaria Transmission of Iran.
Salavatifar M; Zakeri S; Abouie Mehrizi A; Mirkhazemi S; Dinparast Djadid N
Arch Iran Med; 2015 Dec; 18(12):834-43. PubMed ID: 26621016
[TBL] [Abstract][Full Text] [Related]
6. Plasmodium vivax malaria in Sri Lanka: transmission, disease and immunity.
Carter R; David P; Mendis K
Parassitologia; 1993 Jul; 35 Suppl():17-8. PubMed ID: 8233604
[TBL] [Abstract][Full Text] [Related]
7. Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1.
Rodrigues MH; Rodrigues KM; Oliveira TR; Cômodo AN; Rodrigues MM; Kocken CH; Thomas AW; Soares IS
Int J Parasitol; 2005 Feb; 35(2):185-92. PubMed ID: 15710439
[TBL] [Abstract][Full Text] [Related]
8. Comparison of IgG reactivities to Plasmodium vivax merozoite invasion antigens in a Brazilian Amazon population.
Tran TM; Oliveira-Ferreira J; Moreno A; Santos F; Yazdani SS; Chitnis CE; Altman JD; Meyer EV; Barnwell JW; Galinski MR
Am J Trop Med Hyg; 2005 Aug; 73(2):244-55. PubMed ID: 16103583
[TBL] [Abstract][Full Text] [Related]
9. Plasmodium vivax apical membrane antigen-1: comparative recognition of different domains by antibodies induced during natural human infection.
Múfalo BC; Gentil F; Bargieri DY; Costa FT; Rodrigues MM; Soares IS
Microbes Infect; 2008 Oct; 10(12-13):1266-73. PubMed ID: 18692152
[TBL] [Abstract][Full Text] [Related]
10. Antibody responses within two leading Plasmodium vivax vaccine candidate antigens in three geographically diverse malaria-endemic regions of India.
Kale S; Yadav CP; Rao PN; Shalini S; Eapen A; Srivasatava HC; Sharma SK; Pande V; Carlton JM; Singh OP; Mallick PK
Malar J; 2019 Dec; 18(1):425. PubMed ID: 31842894
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin GM 3 23 5,13,14 phenotype is strongly associated with IgG1 antibody responses to Plasmodium vivax vaccine candidate antigens PvMSP1-19 and PvAMA-1.
Pandey JP; Morais CG; Fontes CJ; Braga EM
Malar J; 2010 Aug; 9():229. PubMed ID: 20696056
[TBL] [Abstract][Full Text] [Related]
12. Humoral immune responses against the malaria vaccine candidate antigen Plasmodium vivax AMA-1 and IL-4 gene polymorphisms in individuals living in an endemic area of the Brazilian Amazon.
Tomaz FM; da Cruz Furini AA; Capobianco MP; Póvoa MM; Trindade PC; Fraga VD; Conceição LM; de Azevedo LR; Oliani SM; Cassiano GC; Cavasini CE; Dos Santos SE; Machado RL
Cytokine; 2015 Aug; 74(2):273-8. PubMed ID: 25922277
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to epitopes on merozoite and sporozoite surface antigens as serologic markers of malaria transmission: studies at a site in the dry zone of Sri Lanka.
Ramasamy R; Nagendran K; Ramasamy MS
Am J Trop Med Hyg; 1994 May; 50(5):537-47. PubMed ID: 7515593
[TBL] [Abstract][Full Text] [Related]
14. Anti-circumsporozoite protein antibodies measure age related exposure to malaria in Kataragama, Sri Lanka.
Mendis C; Del Giudice G; Gamage-Mendis AC; Tougne C; Pessi A; Weerasinghe S; Carter R; Mendis KN
Parasite Immunol; 1992 Jan; 14(1):75-86. PubMed ID: 1557232
[TBL] [Abstract][Full Text] [Related]
15. IgG antibody profile to c-terminal region of Plasmodium vivax merozoite surface protein-1 in Thai individuals exposed to malaria.
Pitabut N; Panichakorn J; Mahakunkijcharoen Y; Hirunpetcharat C; Looareesuwan S; Khusmith S
Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):1-7. PubMed ID: 17539238
[TBL] [Abstract][Full Text] [Related]
16. Plasmodium vivax recombinant vaccine candidate AMA-1 plays an important role in adaptive immune response eliciting differentiation of dendritic cells.
Bueno LL; Morais CG; Soares IS; Bouillet LE; Bruna-Romero O; Fontes CJ; Fujiwara RT; Braga EM
Vaccine; 2009 Sep; 27(41):5581-8. PubMed ID: 19651176
[TBL] [Abstract][Full Text] [Related]
17. Human T cell proliferative responses to Plasmodium vivax antigens: evidence of immunosuppression following prolonged exposure to endemic malaria.
Goonewardene R; Carter R; Gamage CP; Del Giudice G; David PH; Howie S; Mendis KN
Eur J Immunol; 1990 Jun; 20(6):1387-91. PubMed ID: 2196178
[TBL] [Abstract][Full Text] [Related]
18. Antibody responses to Plasmodium falciparum and P. vivax sporozoites in areas with stable and unstable malaria.
Del Giudice G; Lambert PH; Mendis K; Pessi A; Tanner M
Bull World Health Organ; 1990; 68 Suppl(Suppl):191-6. PubMed ID: 2094587
[TBL] [Abstract][Full Text] [Related]
19. Plasmodium vivax VIR Proteins Are Targets of Naturally-Acquired Antibody and T Cell Immune Responses to Malaria in Pregnant Women.
Requena P; Rui E; Padilla N; Martínez-Espinosa FE; Castellanos ME; Bôtto-Menezes C; Malheiro A; Arévalo-Herrera M; Kochar S; Kochar SK; Kochar DK; Umbers AJ; Ome-Kaius M; Wangnapi R; Hans D; Menegon M; Mateo F; Sanz S; Desai M; Mayor A; Chitnis CC; Bardají A; Mueller I; Rogerson S; Severini C; Fernández-Becerra C; Menéndez C; Del Portillo H; Dobaño C
PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005009. PubMed ID: 27711158
[TBL] [Abstract][Full Text] [Related]
20. Naturally acquired antibodies to Plasmodium vivax blood-stage vaccine candidates (PvMSP-1₁₉ and PvMSP-3α₃₅₉₋₇₉₈ and their relationship with hematological features in malaria patients from the Brazilian Amazon.
Mourão LC; Morais CG; Bueno LL; Jimenez MC; Soares IS; Fontes CJ; Guimarães Lacerda MV; Xavier MS; Barnwell JW; Galinski MR; Braga EM
Microbes Infect; 2012 Aug; 14(9):730-9. PubMed ID: 22445906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
